Pacific Biosciences of California Inc
PACB
Market Cap$310.59M
Close$
$5.61
449.7% upside
Current Fair Value
449.7% upsideUndervalued by 449.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $310.59 Million |
|---|---|
| Enterprise Value | $587.91 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.12 |
| Beta | 2.19 |
| Outstanding Shares | 296,858,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.47 |
|---|---|
| PEG | -0.1 |
| Price to Sales | - |
| Price to Book Ratio | 1.02 |
| Enterprise Value to Revenue | 3.86 |
| Enterprise Value to EBIT | -0.88 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.13 |
| Debt to Equity | 1.15 |
Revenue Sources
No data
Insider Trades
ESG Score
No data